Literature DB >> 168797

Canine adenovirus type 2-induced immunity to two canine adenoviruses in pups with maternal antibody.

M Appel, L E Carmichael, D S Robson.   

Abstract

Twenty-four Beagle pups with high levels of maternal antibody to canine adenovirus type 1 (CAV-1) and canine adenovirus type 2 (CAV-2) were oronasally inoculated with CAV-2 at 4 weeks of age. The CAV-2 was isolated from pharyngeal swabs on postinoculation days 2 through 6. In spite of the infection, maternal antibody continued to decrease for 4 to 8 postinoculation weeks, and then homologous CAV-2 neutralizing antibody and, to a lesser extent, CAV-1 neutralizing antibody began to increase. When these pups were challenge inoculated with CAV-1 and CAV-2 at a time when maternal antibody to CAV-1 would normally have disappeared, they were immune. In addition, 3 pups with maternal antibody to CAV-1 and CAV-2 were intramuscularly inoculated with CAV-2 at 3 weeks of age. Virus was not isolated from these pups, and maternal antibody decreased at a normal rate. These pups were not immune to challenge inoculation with CAV-1 and CAV-2.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168797

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

Review 1.  Forty years of canine vaccination.

Authors:  M J Appel
Journal:  Adv Vet Med       Date:  1999

Review 2.  The challenges in developing effective canine infectious respiratory disease vaccines.

Authors:  Judy A Mitchell; Joe Brownlie
Journal:  J Pharm Pharmacol       Date:  2015-03-03       Impact factor: 3.765

3.  Prevalence and risk factors for viral exposure in rural dogs around protected areas of the Atlantic forest.

Authors:  Nelson Henrique de Almeida Curi; Rodrigo Lima Massara; Ana Maria de Oliveira Paschoal; Amanda Soriano-Araújo; Zélia Inês Portela Lobato; Guilherme Ramos Demétrio; Adriano Garcia Chiarello; Marcelo Passamani
Journal:  BMC Vet Res       Date:  2016-01-28       Impact factor: 2.741

4.  Development of indirect ELISA for the detection of canine adenovirus type 2 antibodies in dog sera.

Authors:  Dong Kun Yang; Ha Hyun Kim; Siu Lee; Dongryul Oh; Jae Young Yoo; Bang Hun Hyun
Journal:  J Vet Sci       Date:  2020-07       Impact factor: 1.672

5.  Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs.

Authors:  Dong-Kun Yang; Ha-Hyun Kim; Jae Young Yoo; Miryeon Ji; Bok Hee Han; Subin Oh; Bang-Hun Hyun
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31

Review 6.  Canine adenoviruses and herpesvirus.

Authors:  Nicola Decaro; Vito Martella; Canio Buonavoglia
Journal:  Vet Clin North Am Small Anim Pract       Date:  2008-07       Impact factor: 2.093

7.  Immunization of puppies in the presence of maternally derived antibodies against canine distemper virus.

Authors:  M C Pardo; P Tanner; J Bauman; K Silver; L Fischer
Journal:  J Comp Pathol       Date:  2007-06-08       Impact factor: 1.311

8.  Canine adenovirus type 1 causing neurological signs in a 5-week-old puppy.

Authors:  Samuel J Hornsey; Hélène Philibert; Dale L Godson; Elisabeth C R Snead
Journal:  BMC Vet Res       Date:  2019-11-21       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.